OR WAIT null SECS
February 14, 2018
Ferring Pharmaceuticals will expand its biologics capabilities at its headquarters and manufacturing site in Saint-Prex, Switzerland.
February 09, 2018
The acquisition strengthens an already existing collaboration between the companies to advance clinical development of therapies across multiple drug categories.
February 07, 2018
Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.
February 06, 2018
Paratek has completed submission of two new drug applications for oral and intravenous omadacycline, a new antibiotic for pneumonia and skin infections.
Amgen plans to invest approximately $300 million in a new biomanufacturing plant in the United States.
February 02, 2018
Shire will receive exclusive license to develop and commercialize AB Biosciences' pan receptor interacting molecule program for autoimmune and inflammatory diseases.
January 30, 2018
A manufacturing disruption has led to an EpiPen shortage in Canada, which currently has no alternative auto-injectors available on the market.
January 24, 2018
The acquisition builds on the companies' earlier collaboration to develop T-cell-based therapeutics.
The company will invest $139 million in sterile manufacturing technology at its facility in Ballytivnan, Sligo, Ireland to support the growth of its oncology pipeline.
January 18, 2018
The company is developing a pipeline of combination therapies using its patented polymer-based matrix delivery system, known as TAOS (targeted orchestrated signalling matrix).